Skip to main content

Advertisement

Log in

Serum vitamin D level and bone mineral density in premenopausal Egyptian women with fibromyalgia

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Patients with fibromyalgia syndrome (FMS) have impaired mobility and therefore get less sunlight exposure, we postulated that they may be at increased risk of developing osteoporosis (OP). The aim of this study was to assess and compare serum vitamin D level and bone mineral density (BMD) value in patients with primary FMS (PFMS) and healthy controls. A total of 50 patients with PFMS participated in this case–control study, and 50 healthy females who were age-matched to the patients were used as the control group. Venous blood samples collected from all subjects were used to evaluate serum 25-hydroxyvitamin D3 (25-OHD). BMD was measured at the lumbar spine (L2–L4) anteroposterior, femoral neck and forearm by dual-energy X-ray absorptiometry. Patients with PFMS had significantly lower serum 25-OHD than controls (15.1 ± 6.1 and 18.8 ± 5.4 ng/ml, respectively, p = 0.0018). Apart from the BMD in the lumbar spine, which was significantly lower in the PFMS patients compared with controls (p = 0.0012), no significant difference was found in other measures of BMD. Compared to PFMS patients who had serum level of the 25-OHD >20 ng/ml, the patients with 25-OHD ≤20 ng/ml are more likely to have impaired short memory (46.4 vs. 13.6%, respectively, p = 0.0136), confusion (50 vs. 18.2%, respectively, p = 0.0199), mood disturbance (60.7 vs. 27.3%, respectively, p = 0.0185), sleep disturbance (53.6 vs. 22.7%, respectively, p = 0.0271), restless leg syndrome (57.1 vs. 27.3%, respectively, p = 0.0346) and palpitation (67.9 vs. 36.4%, respectively, p = 0.0265). Serum level of the 25-OHD is inversely correlated with visual analogue scale (VAS) of pain (p = 0.016), Beck score for depression (p = 0.020) and BMD at lumbar spine (p = 0.012). The lumbar BMD inversely correlated with VAS of pain (p = 0.013) and Beck score for depression (p = 0.016). This study confirmed high prevalence of hypovitaminosis D among in patients with PFMS. This study confirmed the concept that FMS is a risk factor for OP. Based on this, an early nutrition program rich in calcium and vitamin D, appropriate exercise protocols, and medical treatment should be considered in these patients in terms of preventing OP development.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL et al (1990) The American college of rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum 33:160–172

    Article  PubMed  CAS  Google Scholar 

  2. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L (1995) The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 38:19–28

    Article  PubMed  CAS  Google Scholar 

  3. Goldenberg DL (1989) Psychiatric and psychologic aspects of fibromyalgia syndrome. Rheum Dis Clin North Am 15:105–114

    PubMed  CAS  Google Scholar 

  4. Yunus MB, Ahles TA, Aldag JC, Masi AT (1991) Relationship of clinical features with psychological status in primary fibromyalgia. Arthritis Rheum 34:15–21

    Article  PubMed  CAS  Google Scholar 

  5. Kop WJ, Lyden A, Berlin AA, Ambrose K, Olsen C, Gracely RH et al (2005) Ambulatory monitoring of physical activity and symptoms in fibromyalgia and chronic fatigue syndrome. Arthritis Rheum 52:296–303

    Article  PubMed  Google Scholar 

  6. Eskandari F, Martinez PE, Torvik S, Phillips TM, Sternberg EM, Mistry S et al (2007) Low bone mass in premenopausal women with depression. Arch Intern Med 26(167):2329–2336

    Article  Google Scholar 

  7. Kroger H, Tuppurainen M, Honkanen R, Alhava E, Saarikoski S (1994) Bone mineral density and risk factors for osteoporosis—a population-based study of 1600 perimenopausal women. Calcif Tissue Int 55:1–7

    Article  PubMed  CAS  Google Scholar 

  8. Kanis JA, Delmas P, Burckhardt P, Cooper C, Torgerson D (1997) Guidelines for diagnosis and management of osteoporosis. Osteoporosis Int 7:390–406

    Article  CAS  Google Scholar 

  9. Hamalainen H, Kaarela K, Kroger H, Kauppi M, Jarvenpaa S, Hakala M et al (2007) Changes in bone mineral density in premenopausal women with rheumatoid arthritis during a two-year follow-up. Joint Bone Spine 74:482–487

    Article  PubMed  Google Scholar 

  10. Swezey RL, Adams J (1999) Fibromyalgia: a risk factor for osteoporosis. J Rheumatol 26:2642–2644

    PubMed  CAS  Google Scholar 

  11. Gold DT, Solimeo S (2006) Osteoporosis and depression: a historical perspective. Curr Osteoporos Rep 4:134–139

    Article  PubMed  Google Scholar 

  12. Jacobsen S, Gam A, Egsmose C, Olsen M, Danneskiold-Samsøe B, Jensen GF (1993) Bone mass and turnover in fibromyalgia. J Rheumatol 20(5):856–859

    PubMed  CAS  Google Scholar 

  13. Huskisson EC (1983) Visual analog scales. In: Melzack R (ed) Pain measurement and assessment. Raven, New York, pp 33–37

    Google Scholar 

  14. Burckhardt CS, Clark SR, Bennett RM (1991) The fibromyalgia impact questionnaire: development and validation. J Rheumatol 18:728–733

    PubMed  CAS  Google Scholar 

  15. Salen BA, Spangfort EV, Nygren AL, Nordemar R (1994) The disability rating index: an instrument for the assessment of disability in clinical sitting. J Clin Epidemiol 47:1423–1435

    Article  PubMed  CAS  Google Scholar 

  16. Fries JF, Spitz PW, Karines RG, Holman HR (1980) Measurement patient outcome in arthritis. Arthritis Rheum 23:137–145

    Article  PubMed  CAS  Google Scholar 

  17. Jenkins CD, Stantom BA, Niemcryk SJ, Rose RM (1988) A scale for the estimation of sleep problems in clinical research. J Clin Epidemiol 41:313–321

    Article  PubMed  CAS  Google Scholar 

  18. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J (2003) Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 4:101–119

    Article  PubMed  Google Scholar 

  19. Beck AT, Steer RA, Garbin MG (1988) Psychometric properties of the beck depression inventory: twenty-five years of evaluation. Clin Psychol Rev 8:77–100

    Article  Google Scholar 

  20. Plotnikoff GA, Quigley JM (2003) Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain. Mayo Clin Proc 78(12):1463–1470

    Article  PubMed  Google Scholar 

  21. Block SR (2004) Vitamin D deficiency is not associated with nonspecific musculoskeletal pain syndromes including fibromyalgia. Mayo Clin Proc 79(12):1585–1586

    Article  PubMed  Google Scholar 

  22. WHO (1994) Assessment of osteoporotic fracture risk and its role in screening for postmenopausal osteoporosis, WHO Technical Report Series 843, Geneva

  23. Arnson Y, Amital H, Shoenfeld Y (2007) Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis 66:1137–1142

    Article  PubMed  CAS  Google Scholar 

  24. Perez-Fernandez R, Alonso M, Segura C, Munez I, Garcia-Caballero T, Dignez C (1997) Vitamin D receptor gene expression in human pituitary gland. Life Sci 60:35–42

    Article  PubMed  CAS  Google Scholar 

  25. Nellen JF, Smulders YM, Jos Frissen PH, Slaats EH, Silberbusch J (1996) Hypovitaminosis D in immigrant women: slow to be diagnosed. BMJ 312(7030):570–572

    Article  PubMed  CAS  Google Scholar 

  26. Erkal MZ, Wilde J, Bilgin Y et al (2006) High prevalence of vitamin D deficiency, secondary hyperparathyroidism and generalized bone pain in Turkish immigrants in Germany: identification of risk factors. Osteoporos Int 7(8):1133–1140

    Article  Google Scholar 

  27. Reed SD, Laya MB, Melville J, Ismail SY, Mitchell CM, Ackerman DR (2007) Prevalence of vitamin D insufficiency and clinical associations among veiled East African women in Washington State. J Womens Health (Larchmt) 16(2):206–213

    Article  Google Scholar 

  28. Armstrong DJ, Meenagh GK, Bickle I, Lee AS, Curran ES, Finch MB (2007) Vitamin D deficiency is associated with anxiety and depression in fibromyalgia. Clin Rheumatol 26:551–554

    Article  PubMed  CAS  Google Scholar 

  29. Ganj V, Milone C, Cody MM, McCarty F, Wang YT (2010) Serum vitamin D concentrations are related to depression in young adult US population: the Third National Health and Nutrition Examination Survey. Int Arch Med 3:29

    Article  Google Scholar 

  30. Mouyis M, Ostor AJ, Crisp AJ et al (2008) Hypovitaminosis D among rheumatology outpatients in clinical practice. Rheumatology (Oxford) 47(9):1267–1268

    Article  Google Scholar 

  31. Warner A, Arnspiger SA (2008) Diffuse musculoskeletal pain is not associated with low vitamin D levels or improved by treatment with vitamin D. J Clin Rheumatol 14(1):12–16

    Article  PubMed  Google Scholar 

  32. Al-Allaf AW, Mole PA, Paterson CR, Pullar T (2003) Bone health in patients with fibromyalgia. Rheumatology (Oxford) 42(120):2–6

    Google Scholar 

  33. Tandeter H, Mirta G, Irene Z, Shraga S, Pesach S (2009) Serum 25-OH vitamin D levels in patients with fibromyalgia. IMAJ 11:339–342

    PubMed  Google Scholar 

  34. Engelsen O, Brustad M, Aksnes L, Lund E (2005) Daily duration of vitamin D synthesis in human skin with relation to latitude, total ozone, altitude, ground cover, aerosols and cloud thickness. Photochem Photobiol 81(6):1287–1290

    Article  PubMed  CAS  Google Scholar 

  35. Hollis BW (2005) Circulating 25-hydroxyvitamin D 11. Levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 135(2):317–322

    PubMed  CAS  Google Scholar 

  36. Holick MF (2007) Vitamin D deficiency. N Engl J Med 357(3):266–281

    Article  PubMed  CAS  Google Scholar 

  37. Tander B, Akyol Y, Durmuş D, Alaylı G, Cengiz K, İlhanl İ, Ulus Y, Cantürk F (2010) Bone mineral density and depression in premenopausal women with primary fibromyalgia syndrome. Turk J Rheumatol 25:105–109

    Article  Google Scholar 

  38. Erdal A, Yıldırım K, Hacıbeyoğlu H, Yıldırım M, Şenel K (2003) Fibromyalgia syndrome, bone mineral density values: is it a risk factor for osteoporosis? Osteoporoz Dünyasından 9:59–62

    Google Scholar 

  39. Zerahn B, Bliddal H, Møller P, Borgwardt A, Danneskiold-Samsøe B (2001) Bone mass in the calcaneus in patients with fibromyalgia. J Musculoskeletal Pain 9:17–23

    Article  Google Scholar 

  40. Jensen B, Wittrup IH, Bliddal H, Danneskiold-Samsoe B, Faber J (2003) Bone mineral density in fibromyalgia patients-correlation to disease activity. Scand J Rheumatol 32:146–150

    Article  PubMed  CAS  Google Scholar 

  41. Yesevi B, Adam M, Leblebici B, Elden H (2005) The effect of obesity, bone mineral density in patients with primary fibromyalgia. Osteoporoz Dünyasından 11:148–150

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shereem Mohamed Olama.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Olama, S.M., Senna, M.K., Elarman, M.M. et al. Serum vitamin D level and bone mineral density in premenopausal Egyptian women with fibromyalgia. Rheumatol Int 33, 185–192 (2013). https://doi.org/10.1007/s00296-012-2361-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-012-2361-0

Keywords

Navigation